MF

White Blood Cells - Part 1: Granulocytes & Monocytes

Learning Outcomes

  • Knowledge of the functions of white blood cells, including their roles in immunity, phagocytosis, and inflammatory responses.

  • Knowledge of the microscopic appearance of the white blood cells, enabling identification and differentiation of each type.

  • Understanding of the representation of white blood cells in the full blood count, including absolute and relative counts.

  • Understanding of the indications for disease diagnosis that the differential white blood cell count provides, such as infections, allergies, and immune disorders.

Overview

  • Each type of white blood cell (WBC) has a specific function, contributing to the body's defense mechanisms.

  • Differential diagnosis can often be suggested based on:

    • How WBCs are represented in the full blood count (FBC), providing quantitative data.

    • Their microscopic appearance, offering qualitative insights.

Basic Function

  • WBCs are responsible for immunity, mainly through phagocytosis, which is crucial for clearing pathogens and debris.

  • Phagocytosis: Ingestion and destruction of foreign and unwanted material like bacteria, old red blood cells, and cellular debris.

  • Phagocytes: Cells that perform phagocytosis, primarily neutrophils, monocytes, and macrophages, each with specific roles and mechanisms.

Leukocytes

  • WBCs, or leukocytes, are cellular components of the immune system, defending the body against infections and foreign substances.

  • The body maintains a specific concentration of WBCs in peripheral blood for efficient immune function, ensuring a rapid response to threats.

  • Adult reference range: WBC 4 – 11 \times 10^9/L.

  • Hematology analyzer provides automated white cell count with parameters like:

    • WBC High: Leucocytosis, indicating infection, inflammation, or other conditions.

    • WBC Low: Leucopenia, suggesting immune suppression or bone marrow disorders.

Haematopoiesis

  • With the exception of T cells, all WBCs are produced and mature in the Bone Marrow (BM), the primary site of hematopoiesis.

  • The BM contains a reservoir of immature WBCs to supplement the peripheral blood population when needed, ensuring a continuous supply of immune cells.

  • The BM contains more WBCs than RBCs, reflecting the high turnover and demand for immune cells.

  • Myeloid lineage development:

    • Multipotent stem cell → Common myeloid progenitor, the precursor for granulocytes, monocytes, and macrophages.

Granulocytes

  • Contain cytoplasmic granules, which are filled with enzymes and antimicrobial substances.

  • Effector cells: Mature, fully functional cells capable of performing specific immune functions.

  • In healthy individuals, only mature effector cells are present in the peripheral blood; reserves of developing cells remain in the BM, ready for rapid deployment.

Neutrophils

  • Approximately 10^{11} neutrophils are produced daily by the BM, highlighting their critical role in immune defense.

  • Short lifespan: 6 hours - 5 days circulating in the peripheral blood (PB) and marginating in reticuloendothelial tissues, allowing for rapid response to infections.

  • Primary cellular component of the innate immune system, providing immediate and non-specific defense against pathogens.

Neutrophil Response

  • Highly sensitive to chemotactic stimuli, enabling rapid migration to sites of infection and inflammation.

  • Rapid migration to the site of inflammation, directed by chemical signals released by infected tissues.

  • Marginating cells are available for immediate mobilization, adhering to blood vessel walls and ready to enter tissues.

  • 'First responders' of the immune system, quickly arriving at the site of infection to phagocytose pathogens and release antimicrobial substances.

Neutrophil Count

  • Most abundant WBC species, typically comprising 50-70% of circulating WBCs.

  • Neutrophilia: High neutrophil count, often indicative of bacterial infection or inflammation.

  • Neutropenia: Low neutrophil count, increasing the risk of infection.

  • Reference ranges:

    • WBC: 4.0 – 11.0 \times 10^9/L

    • NEUT (Absolute count): 2.0 – 8.0 \times 10^9/L

    • NEUT (Percentage): 50 – 70%

Neutrophil Morphology

  • 3 - 5 nuclear lobes joined by chromatin bridges, a distinctive feature for identification.

  • Azurophilic cytoplasmic granules, containing enzymes and antimicrobial substances.

Neutrophil Granules

  • Primary granules:

    • Myeloperoxidase (MPO), involved in the production of hypochlorous acid, a potent antimicrobial agent.

    • Bacterial permeability inducing factor (BPI) – effective against gram-negative bacteria, disrupting their cell membranes.

    • Lysozyme – effective against gram-positive bacteria, breaking down their cell walls.

    • Elastase – effective against gram-positive, gram-negative, fungi, enterotoxins, degrading proteins and contributing to tissue damage.

    • Acid hydrolases, involved in the breakdown of phagocytosed material.

  • Secondary granules:

    • Lactoferrin – iron-binding; bacteriostatic and bactericidal, depriving bacteria of essential iron.

  • Tertiary granules:

    • Gelatinase (MMP) – digests vessel basement membrane, facilitating migration through tissues.

  • Granule release pattern during granulopoiesis (granule development), ensuring appropriate enzyme availability.

Eosinophils

  • Principally involved in immunity against helminth infections (roundworm, hookworm, Schistosomiasis), releasing toxic substances to kill parasites.

  • Contribute to hypersensitivity reactions, such as asthma and allergies, by releasing inflammatory mediators.

  • Develop in the BM, and mature effector cells are released into the PB, ready to migrate to sites of inflammation.

  • BM reserve, but no marginal reserve in periphery, indicating limited availability for immediate mobilization.

Eosinophil Count

  • Minor granulocyte species, typically comprising 1-3% of circulating WBCs.

  • Eosinophilia: High eosinophil count, often associated with parasitic infections or allergic reactions.

  • Reference range:

    • EOSO (Absolute count): 0.0 – 0.5 \times 10^9/L

    • WBC: 4.0 – 11.0 \times 10^9/L

Eosinophil Morphology

  • Bilobed nucleus, a characteristic feature for identification.

  • Large orange-red cytoplasmic granules, containing toxic substances.

Eosinophil Granules

  • Major basic protein – disrupts the lipid bilayer of parasites, causing cell lysis.

  • Eosinophil peroxidase – bactericidal, producing reactive oxygen species.

  • Eosinophil cationic protein – helminthotoxic and bactericidal, damaging parasite cell membranes.

  • Eosinophil-derived neurotoxin – helminthotoxic and bactericidal, affecting parasite nerve function.

Basophils

  • Principally involved in hypersensitivity reactions (allergy), releasing histamine and other inflammatory mediators.

  • Contribute to anti-helminth immunity, although their role is less prominent than eosinophils.

  • Develop in the BM, and mature effector cells are released into the PB, where they circulate and respond to inflammatory signals.

  • BM reserve, but no marginal reserve in periphery, suggesting limited immediate availability.

Basophil Count

  • Least abundant granulocyte species, typically comprising less than 1% of circulating WBCs.

  • Basophilia: High basophil count, often associated with allergic reactions or myeloproliferative disorders.

  • Reference range:

    • BASO (Absolute count): 0.0 – 0.1 \times 10^9/L

    • WBC: 4.0 – 11.0 \times 10^9/L

Basophil Morphology

  • Indented or bilobed nucleus, often obscured by granules.

  • Abundant large purple-black cytoplasmic granules, containing various inflammatory mediators.

  • Contain mucopolysaccharides (e.g., Heparin) and Histamine (involved in inflammation and vascular permeability), contributing to allergic reactions.

Monocytes

  • Not terminally differentiated 'effector' cells, but rather precursors to macrophages and dendritic cells.

  • Bloodborne stage in the development of tissue macrophages, circulating in the bloodstream before migrating into tissues.

  • Circulate in PB for 2 – 3 days, during which they can respond to inflammatory signals.

  • Migrate out of blood vessels into surrounding tissues and differentiate into macrophages, which are phagocytic cells that remove debris and pathogens.

  • Macrophage → 'effector' cell, also known as histiocytes, residing in tissues and performing immune functions.

  • Macrophage/histiocyte lifespan can be several months, allowing for long-term immune surveillance.

Monocyte Count

  • Myeloid cell but NOT a granulocyte, distinguishing them from neutrophils, eosinophils, and basophils.

  • Monocytosis: High monocyte count, often associated with chronic infections, inflammation, or malignancy.

  • Monocytopenia: Low monocyte count (rare), suggesting immune suppression or bone marrow failure.

  • Reference ranges:

    • MONO (Absolute count): 0.4 – 1.0 \times 10^9/L

    • WBC: 4.0 – 11.0 \times 10^9/L

Monocyte Morphology

  • Highly indented 'C shaped' nucleus, a characteristic feature for identification.

  • Pale greyish-blue cytoplasm, often containing vacuoles.

  • Few small azurophilic cytoplasmic granules, containing enzymes and antimicrobial substances.

  • Contain digestive enzymes relevant for macrophage function, enabling the breakdown of phagocytosed material.

#